BOXED O
WARNING O
: O
WARNING O
: O
SUICIDALITY O
AND O
ANTIDEPRESSANT O
DRUGS O
WARNING O
: O
SUICIDALITY O
AND O
ANTIDEPRESSANT O
DRUGS O
Savella O
is O
a O
selective O
serotonin O
and O
norepinephrine O
reuptake O
inhibitor O
( O
SNRI O
) O
, O
similar O
to O
some O
drugs O
used O
for O
the O
treatment O
of O
depression B-Not_AE_Candidate
and O
other O
psychiatric B-Not_AE_Candidate
disorders I-Not_AE_Candidate
. O

Antidepressants O
increased O
the O
risk O
compared O
to O
placebo O
of O
suicidal B-OSE_Labeled_AE
thinking I-OSE_Labeled_AE
and O
behavior O
( O
suicidality B-OSE_Labeled_AE
) O
in O
children O
, O
adolescents O
, O
and O
young O
adults O
in O
short-term O
studies O
of O
major B-Not_AE_Candidate
depressive I-Not_AE_Candidate
disorder I-Not_AE_Candidate
( I-Not_AE_Candidate
MDD I-Not_AE_Candidate
) O
and O
other O
psychiatric B-Not_AE_Candidate
disorders I-Not_AE_Candidate
. O

Anyone O
considering O
the O
use O
of O
such O
drugs O
in O
a O
child O
, O
adolescent O
, O
or O
young O
adult O
must O
balance O
this O
risk O
with O
the O
clinical O
need O
. O

Short-term O
studies O
did O
not O
show O
an O
increase O
in O
the O
risk O
of O
suicidality B-NonOSE_AE
with O
antidepressants O
compared O
to O
placebo O
in O
adults O
beyond O
age O
24 O
; O
there O
was O
a O
reduction O
in O
risk O
with O
antidepressants O
compared O
to O
placebo O
in O
adults O
aged O
65 O
and O
older O
. O

Depression B-Not_AE_Candidate
and O
certain O
other O
psychiatric B-Not_AE_Candidate
disorders I-Not_AE_Candidate
are O
themselves O
associated O
with O
increases O
in O
the O
risk O
of O
suicide B-NonOSE_AE
. O

Patients O
of O
all O
ages O
who O
are O
started O
on O
Savella O
should O
be O
monitored O
appropriately O
and O
observed O
closely O
for O
clinical O
worsening O
, O
suicidality B-NonOSE_AE
, O
or O
unusual B-NonOSE_AE
changes I-NonOSE_AE
in I-NonOSE_AE
behavior I-NonOSE_AE
. O

Families O
and O
caregivers O
should O
be O
advised O
of O
the O
need O
for O
close O
observation O
and O
communication O
with O
the O
prescriber O
. O

Savella O
is O
not O
approved O
for O
use O
in O
the O
treatment O
of O
major B-Not_AE_Candidate
depressive I-Not_AE_Candidate
disorder I-Not_AE_Candidate
. O

Savella O
is O
not O
approved O
for O
use O
in O
pediatric O
patients O
[ O
see O
Indications O
and O
Usage O
( O
1 O
) O
, O
Warnings O
and O
Precautions O
( O
5.1 O
) O
, O
Use O
in O
Specific O
Populations O
( O
8.4 O
) O
] O
. O

EXCERPT O
: O
WARNING O
: O
SUICIDALITY O
AND O
ANTIDEPRESSANT O
DRUGS O
See O
full O
prescribing O
information O
for O
complete O
boxed O
warning O
. O

* O
Increased O
risk O
of O
suicidal O
ideation O
, O
thinking O
, O
and O
behavior O
in O
children O
, O
adolescents O
, O
and O
young O
adults O
taking O
antidepressants O
for O
major O
depressive O
disorder O
( O
MDD O
) O
and O
other O
psychiatric O
disorders O
( O
5.1 O
) O
. O

* O
Savella O
is O
not O
approved O
for O
use O
in O
pediatric O
patients O
( O
1 O
, O
8.4 O
) O
. O

